Biogen's Q2 2026 Earnings: What to Expect

Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.

to the point: Healthcare & Life Sciences Q2/2026

How Direct Digital Investing can pave the way to the Stock Market

Q2-2026 Earnings Season Preview: Bank Optimism Tempered by Tech Correction Risk

The article previews the upcoming Q2-2026 earnings season, predicting that major banks will beat expectations by reducing bad-loan provision

Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy?

Syngene FY26 profit falls 20%, revenue rises 3%